Life Science Company News

Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Ann

Read more ››
By: GlobeNewswire - 30 Apr 2024

X4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

SIRPant Immunotherapeutics to Participate in Wells Fargo Virtual Private Biotech Symposium

Read more ››
By: GlobeNewswire - 30 Apr 2024

Appendix 4C & Quarterly Business Update – March 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

OrthoSelect announces release of DIBS AI® 8.0 with significant new features to speed and simplify digital indirect bonding for orthodontists

Read more ››
By: GlobeNewswire - 30 Apr 2024

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome

Read more ››
By: GlobeNewswire - 30 Apr 2024

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Read more ››
By: GlobeNewswire - 30 Apr 2024

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

Read more ››
By: GlobeNewswire - 30 Apr 2024

Recce Pharmaceuticals Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Read more ››
By: GlobeNewswire - 30 Apr 2024

Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 30 Apr 2024

Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference

Read more ››
By: GlobeNewswire - 30 Apr 2024

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

Read more ››
By: GlobeNewswire - 30 Apr 2024

Alumis Announces First Participant Dosed in Phase 1 Clinical Trial of CNS Penetrant Allosteric TYK2 Inhibitor A-005

Read more ››
By: GlobeNewswire - 30 Apr 2024

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

Read more ››
By: GlobeNewswire - 30 Apr 2024

Goodness Growth Holdings to Release First Quarter 2024 Results on May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Noom Establishes Its First-Ever Social Impact Program with the Launch of Noom Impact, Providing Free Health Solutions to People in Need

Read more ››
By: GlobeNewswire - 30 Apr 2024

Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)

Read more ››
By: GlobeNewswire - 30 Apr 2024

STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

Read more ››
By: GlobeNewswire - 30 Apr 2024
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate